Shares mag. recommending this stock this week. Is this going to be our killer this christmas!!!! any comments anyone?????

Will remain flatlined for another 6 months.

That's the 2nd time you've mentioned 6 months adam although the last time was back in June. Why will they remain flatlined until March iyo?

Yep,

There is no news expected until mid 2006 now. We may get an update during the first 1/4 which is why I say 6 months, but it could easily be 9 or 10.

I have sold a third of mine during the last spike, but will hold the rest until the news comes, as it should send these into the 20's.

Well best of luck to you, I and all other holders then. Wake me up when the snows thaw.....

Held these for ages, sold the 7.5p Rights Issue allocation for a nice profit. Hanging onto the rest. Problem is that these trials take forever and intense patience required. Exactly the same with AZM at the moment.

good luck

pth

so tell me - what is going on now?

No idea but positive movement for a change.

From what i can see the movement has been because of large buys. Could be some positive news on the way!

It's coming up to 2006. Cenes' big year. The Traders have their year 2005 profits in their pockets - taking money off those not able to stay in for the long run and now they are thinking of 2006.
Those who stayed the run, and were able to, are about to reap the rewards.
Patience is a virtue demanded of others but seldom employed by the self.

It was related to the completion of a large sell order and positive comment yesterday.


Large CeNes Shr Order May Signal Bottom

Wednesday, December 14, 2005 8:38:46 AM ET
Dow Jones Newswires

1224 GMT [Dow Jones] CeNes Pharmaceuticals (CEN.LN) shares could be close to their lows once the execution of a large sell order is completed, says trader. "Piper Jaffray are clearing up a line of 22M CeNes Pharma that has been about for a while," trader says. "This stock has been dripping into the market for a while and I think this could well mark the lows once any flippers are out of the way." Piper Jaffray not immediately available to comment. CeNes shares have fallen from EUR8.50 since late September. Now they're +1.9% at P6.9p. (PBA/DWE)

Dont know anything about this share, but loads of buying including 500,000 shares bought by the boss.

Still happening, big style but the price doesnt move. Why is that?????

stock hangover! brokers obviously have plenty to get rid of and people who bought cheaper cycling out - give it time for the washout and then watch it motor to 12 within 3 months - prob rest there

stock hangover! brokers obviously have plenty to get rid of and people who bought cheaper cycling out - give it time for the washout and then watch it motor to 12 within 3 months - prob rest there

The Guardian said yesterday

Talk that CeNes Pharmaceuticals (LSE: CEN.L - news) could be given the green light by US regulators to start Phase III clinical trials of its treatment for severe post-operative pain.

Shares recommended Aug 2004 and still the same? Oh dear. Phase 3 my arse. And even then it won't necessarily deliver. Just another aim loser.

although i agree with your analysis, will probably trade 4p-12p over the next 6 months. as ever buy on the cannons sell on the bugles. a merry christmas and a profitable new year to all cen players

All research points to cenes rising in '06. I had the same opinion of seo (+200 per cent in '05) this time last year! IMHO & DYOR of course.

Best wishes to all for the new year.

jtf


Info:- http://www.fillyaboots.com/f7/forum_posts.asp?TID=1880&KW=cenes

NEWS:Talk that an institution is about to announce it has taken a 3% stake, lifts CeNes Pharmaceuticals. Hopefully pushes share price upwards

A nice little snippet of news:

CeNeS Pharmaceuticals said it has been granted a patent on its short-acting sedatives by the European Patent Office (EPO).

The patent covers a series of sedative compounds, including CNS 7056X, which are in pre-clinical development.

The EPO is the first to grant the patent.

The company said national applications are pending in other key territories including the US and Japan.

CeNeS' short-acting sedatives are being developed for use in patients undergoing short diagnostic and surgical procedures.